Skip to main content

LENSAR, Inc.

corporate_fare Company Profile

LENSAR, Inc.

LNSR·NASDAQ·Industrial Applications And Services·CIK 0001320350

LENSAR, Inc. is a commercial-stage medical device company that designs, develops, and markets advanced laser systems for treating cataracts and managing pre-existing or surgically induced corneal astigmatism. The company's current systems are the LENSAR Laser System (LLS) and the ALLY Robotic Cataract Laser System (ALLY System). These systems incorporate proprietary technologies to assist surgeons in achieving better visual outcomes, efficiency, and reproducibility through advanced imaging, simplified procedure planning, efficient design, and precision. The ALLY System combines all features of the LLS with a dual-modality laser, integrated into a small, compact cataract treatment system designed for sterile cataract surgery in a single operating room. The ALLY System received U.S. Food and Drug Administration (FDA) clearance in June 2022, with an initial launch in August 2022. It is available to all U.S. and EU cataract surgeons and has also received regulatory clearance in India, Taiwan, and certain other countries. Cataract surgery is one of the highest volume surgical procedures globally and the most common procedure performed by ophthalmic surgeons, according to the American Academy of Ophthalmology (AAO).

LENSAR, Inc. (NASDAQ:LNSR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 16 items for LNSR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for LNSR spans 8-K, 10-Q, 10-K, 8-K/A.

Recent high-impact activity:

  • Lensar Swings to $4.72M Q3 Loss After Profitable Q2
  • LENSAR Q2 Revenue Beats by 13%, Swings to Profit on ALLY Demand
  • LENSAR Q2 Revenue Up 18%, Swings to Profit on Strong ALLY Adoption
  • LENSAR Reports Q1 Net Income of $36.3M Driven by Merger Termination Fee and Warrant Revaluation
  • LENSAR Reports Q1 Profit of $36.3M, Driven by Merger Termination Income and Warrant Revaluation

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$58.44M
Net Income
-$34.28M
Diluted EPS
-$2.87
Op. Cash Flow
-$14.83M
Free Cash Flow
-$14.91M
Gross Profit
$27.12M
Operating Income
-$24.58M
Cash & Equivalents
$12.97M
Debt / Equity
0.00×
Net Margin
-58.7%
Shares Outstanding
11.99M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197477

Short Interest & Short Volume

6.77 days to cover

FINRA reported short interest of 306,208 shares in LNSR as of the October 30, 2026 settlement, a 0.2% decrease from the prior period — about 6.8 days to cover at its recent average daily volume. On November 20, 2026, 40.1% of LNSR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)306,208 shares as of October 30, 2026
Change vs prior period▼ 0.2%
Days to cover6.77 at avg daily volume of 45,261
Daily short volume (FINRA facilities)40.1% of 20,657 shares on November 20, 2026
5-day average short volume58.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with L →
$4.46
52-week range · as of 2026-08-13 $4.46 – $13.08
Market cap
$54.83M
Volume
55K (0.8× avg)
3-mo avg 66.1K
Live data · 2026-11-21 08:27 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LNSR - Latest Insights

LNSR
Nov 10, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.60
Real-time Price: $4.46 info
Change: -$1.14 (-20%) info
Market Cap: $54.832M info
LNSR
Aug 13, 2026, 7:17 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.43
Real-time Price: $4.46 info
Change: -$2.97 (-40%) info
Market Cap: $54.832M info
LNSR
Aug 13, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.20
Real-time Price: $4.46 info
Change: -$2.74 (-38%) info
Market Cap: $54.832M info
LNSR
May 08, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.64
Real-time Price: $4.46 info
Change: -$1.18 (-21%) info
Market Cap: $54.832M info
LNSR
May 08, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.23
Real-time Price: $4.46 info
Change: -$0.770 (-15%) info
Market Cap: $54.832M info
LNSR
May 08, 2026, 7:00 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $5.23
Real-time Price: $4.46 info
Change: -$0.770 (-15%) info
Market Cap: $54.832M info
LNSR
Apr 15, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.13
Real-time Price: $4.46 info
Change: -$1.67 (-27%) info
Market Cap: $54.832M info
LNSR
Mar 31, 2026, 4:14 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $5.96
Real-time Price: $4.46 info
Change: -$1.50 (-25%) info
Market Cap: $54.832M info
LNSR
Mar 31, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.24
Real-time Price: $4.46 info
Change: -$1.78 (-29%) info
Market Cap: $54.832M info
LNSR
Mar 31, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $6.24
Real-time Price: $4.46 info
Change: -$1.78 (-29%) info
Market Cap: $54.832M info
LNSR
Mar 17, 2026, 8:26 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.78
Real-time Price: $4.46 info
Change: -$3.32 (-43%) info
Market Cap: $54.832M info
LNSR
Mar 16, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $10.26
Real-time Price: $4.46 info
Change: -$5.80 (-57%) info
Market Cap: $54.832M info
LNSR
Mar 13, 2026, 6:02 AM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $11.68
Real-time Price: $4.46 info
Change: -$7.22 (-62%) info
Market Cap: $54.832M info
LNSR
Mar 12, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.68
Real-time Price: $4.46 info
Change: -$7.22 (-62%) info
Market Cap: $54.832M info
LNSR
Mar 12, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.68
Real-time Price: $4.46 info
Change: -$7.22 (-62%) info
Market Cap: $54.832M info
LNSR
Feb 25, 2026, 5:09 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.55
Real-time Price: $4.46 info
Change: -$8.09 (-64%) info
Market Cap: $54.832M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets